# Fall Epidemic Viral Pediatric Study

> **NCT01192178** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 339 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** FLOVENT™ DISKUS™ 100 mcg BID
- **DRUG:** ADVAIR™ DISKUS™ 100/50 mcg BID

## Key facts

- **NCT ID:** NCT01192178
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 339 (ACTUAL)
- **Last updated:** 2017-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01192178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01192178, "Fall Epidemic Viral Pediatric Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01192178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*